When assayed on promastigotes of 10 American Leishmania isolates (including Leishmania brasiliensis and mexicana species), 4-aminopyrazolopyrimidine (APP) was severalfold more active than allopurinol as a leishmanistatic drug. There were some intraspecific and interspecific differences among the isolates in their susceptibility to the inhibitory effects of APP and allopurinol. APP-2'-deoxyriboside did not affect the 10 isolates tested. This was surprising, because allopurinol riboside has previously been shown to be more active than allopurinol.
When assayed on promastigotes of 10 American Leishmania isolates (including Leishmania brasiliensis and mexicana species), 4-aminopyrazolopyrimidine (APP) was severalfold more active than allopurinol as a leishmanistatic drug. There were some intraspecific and interspecific differences among the isolates in their susceptibility to the inhibitory effects of APP and allopurinol. APP-2'-deoxyriboside did not affect the 10 isolates tested. This was surprising, because allopurinol riboside has previously been shown to be more active than allopurinol.
In all of the American Leishmania isolates tested, the metabolism of [14C]6-APP resulted in a high level of HPP-ribose-5'-P and lower levels of APP-ribose-5'-P, APP-ribose-5'-PP, and APP-ribose-5'-PPP. MP, LR, LBY, and JAP isolates strongly converted APP into APP derivatives, thus perhaps explaining their greater susceptibility to the inhibitory effects of APP. With the 10 American Leishmania isolates tested, several purines reversed the inhibitory effects of allopurinol, but only adenine countered the inhibitory effects of APP. This suggests biochemical differences in the mechanisms of action of allopurinol and APP. Finally, and contrary to previous claims, the reversal by purines of the allopurinol-induced growth inhibition was not a Leishmania species-specific effect.
In South and Central America, cutaneous and mucocutaneous leishmaniasis are caused by Leishmania mexicana or Leishmania brasiliensis infection (6) . Since the two pyrazolopyrimidines allopurinol (4-hydroxypyrazolo[3,4-dJpyrimidine; HPP) and allopurinol riboside (HPPR) have been shown to be effective in vitro against both American Leishmania species (11, 15) , the effects of 4-aminopyrazolopyrimidine (APP) and APP-2'-deoxyriboside on these species were studied. We have already shown that Trypanosoma cruzi (1) 
RESULTS
Under our culture conditions, the mean dose producing 50%o inhibition compared with control growth (ID50) for all of the 10 American Leishmania isolates tested was about 15 jig/ml for HPP and 2 ,ug/ml for APP (Fig. 1 ). For HPP, the ID50 range from a minimum of 10 ,ug/ml for AZV and HM isolates to a maximum of 20 ,ug/ml for MA, LBY, and BG isolates (Fig. 1) . For APP, the ID50 varied from a minimum of 1 jig/ml for NR, MP, and LR isolates to a maximum of 4 jig/ ml for the AZV isolate. Because of the marked differences in the susceptibility of our different American Leishmania isolates to the inhibitory effects of APP, we studied the effects of very low concentrations of APP on promastigote multiplication. MP, LR, LBY, and JAP isolates (assumed to represent the three American leishmania species in study) were quite susceptible to low concentrations of APP (ID50 was 0.50 ,ug/ ml). The other six Leishmania isolates were only partially inhibited by low concentrations of APP.
In an attempt to explain the interspecific and intraspecific differences in susceptibility among the American Leishmania isolates to the inhibitory effects of APP, we incubated the promastigotes for 48 h with [14C]6-APP. This resulted in its extensive metabolism to nucleotides, the predominant metabolite being HPP-ribose-5'-P, with small amounts of APP-ribose-5'-P, APPribose-5'-PP, and APP-ribose-5'-PPP (Table 1) . When the incubation medium of all Leishmania isolates was examined separately for the presence of metabolites of APP, only a mean value of 12% of the APP was converted to HPP-ribose.
MP, LR, LBY, and JAP isolates strongly converted APP into APP derivatives, thus perhaps explaining their greater susceptibility to the inhibitory effects of APP.
Finally, when cultured into medium free of the drugs, the promastigotes resumed a normal growth rate, thus demonstrating that APP and HPP were only leishmanistatic for Leishmania species.
APP 2'-deoxyriboside even at high concentrations (100 ,ug/ml) was inactive on the 10 American Leishmania isolates tested.
In other experiments, we studied the activities of different purines and pyrimidines in reversing the inhibition of growth of promastigotes of each of the American Leishmania isolates induced by HPP ( Table 2) . Independently of the species studied, adenosine, 2'-deoxyadenosine, guanosine, inosine, adenine, guanine, hypoxanthine, and xanthine totally reversed the inhibitory effect of HPP on all of the 10 American Leishmania isolates tested. However, inhibition induced by APP was reversed only by adenine ( Table 3) .
The similar response for the presence of a given antagonist against HPP or APP added to the culture medium, suggest biochemical similarities between promastigotes of the three American Leishmania species studied in this paper.
DISCUSSION
Our present results, obtained on 10 different isolates, corroborate the inhibitory activity of HPP on American Leishmania reported previously (7, 15) and suggest a stronger leishmanistatic activity of APP. These latter results are similar to those found previously for T. cruzi (1) and T. rangeli (2) and for L. brasiliensis and L. donovani (9) .
Contrary to expectation, APP-2'-deoxyriboside at very high concentrations was inactive as HPPR, on the other hand, is severalfold more active than HPP on American Leishmania species (11). That APP-2'-deoxyriboside was more than 500-fold less active than HPPR against several American Leishmania isolates merits further investigation. It must be pointed out that it has also been demonstrated that HPP and HPPR are converted to their corresponding nucleotides by different enzymatic pathways (11 The intraspecific and interspecific differences in the inhibitory effects of HPP and APP among isolates of American Leishmania contrast with those differences obtained with several T. cruzi (1) and T. rangeli isolates (2), all of which were similarly affected in vitro by a given dose of both pyrazolopyrimidines.
The nonpathogenic LBY isolate was unique, since it was only partially inhibited by both pyrazolopyrimidines.
The capacities of several purines and pyrimidines tested to reverse the activity of HPP confirmed previously published results (7, 9, 15) . According to earlier reports, adenine at 10 times the concentration of HPP did not prevent entry of HPP, but blocked its conversion to nucleoside. Previous results suggested that adenine could deplete PRPP pools either through direct utilization by phosphoribosyltransferase (EC 2.4.2.7 and EC 2.4.2.8) or inhibition of ATP:D-ribose-5-phosphate pyrophosphotransferase (EC 2.7.6.1).
Available information on purine metabolism in L. brasiliensis (8) does not explain why certain purines (xanthine, inosine, hypoxanthine, guanine, and guanosine) are able to block the activity of HPP but are ineffective against the activity of APP.
Our observations on the capacities of inosine, hypoxanthine, guanine, and guanosine to reverse the inhibitory effects of HPP on American Leishmania isolates are different from those recorded by others (7). They suggested that selective reversal of the activity of HPP by uracil, inosine, and hypoxanthine may differen- tiate L. mexicana from L. brasiliensis. Such an action-of uracil was not observed with any of the 10 American Leishmania isolates studied, and therefore these should be classified as L. brasiliensis. However, the growth inhibition of all of our isolates was totally reversed by inosine and hypoxanthine, which is supposedly characteristic of L. mexicana. It is evident that for HPP, the selective reversal effects of purines and pyrimidines are not typical for a given Leishmania species as previously claimed (7, 11) . However, any comparison between those results and our findings is difficult, since neither strain of parasite nor method of cultivation was the same in both laboratories. Nelson et al. (10) recently reported that L. brasiliensis is 100-fold more susceptible than L. mexicana to the inhibitory effects of HPPR, suggesting differences in the activity of allopurinol derivatives on the two American leishmania species.
In conclusion, our results suggest that low doses of APP (0.25 to 1 mg/kg per day) can be used in the successful treatment of American leishmaniasis, as recently described for experimental acute Chagas disease (2) . We have found that the optimal in vivo doses (0.25 mg/kg per day) is about 40-to 100-fold lower the 509o lethal dose reported for APP-treated mice (17) . HPPR has been demonstrated to exert anti-leishmanial activity in vitro and to inhibit cellular immunity (12) . It will be particularly interesting to examine APP from this point of view.
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